Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors. Kim YJ, Jang SK, Kim G, Hong SE, et al. Anticancer Res 2023;43:1973-1980.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim YJ, Jang SK, Kim G, Hong SE, et al. Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors. Anticancer Res 2023;43:1973-1980.
PMID: 37097659